Comparing lansoprazole and omeprazole in onset of heartburn relief: Results of a randomized, controlled trial in erosive esophagitis patients

American Journal of Gastroenterology

Volumn 96, Issue 11, 2001, Pages 3089-3098

  Richter, Joel E ^a   Kahrilas, Peter J ^b   Sontag, Stephen J ^b   Kovacs, Thomas O G ^b   Huang, Bidan ^b   Pencyla, Jennifer L ^b  

^a LERNER RESEARCH INSTITUTE   (United States)

^b Cleveland Clinic Foundation ^*

Author keywords

[No Author keywords available]

Indexed keywords

LANSOPRAZOLE; OMEPRAZOLE;

ADULT; AGED; ARTICLE; ASTHMA; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIARRHEA; DISEASE SEVERITY; DOSE RESPONSE; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; FEMALE; HEARTBURN; HUMAN; MAJOR CLINICAL STUDY; MALE; MELENA; MULTICENTER STUDY; PHASE 3 CLINICAL TRIAL; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; REFLUX ESOPHAGITIS; TIME;

2-PYRIDINYLMETHYLSULFINYLBENZIMIDAZOLES; ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTI-ULCER AGENTS; DOUBLE-BLIND METHOD; ESOPHAGITIS; FEMALE; HEARTBURN; HUMANS; MALE; MIDDLE AGED; OMEPRAZOLE;

EID: 0035189370     PISSN: 00029270     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9270(01)03825-4     Document Type: Article

References (23)

1. Current diagnosis and treatment of gastroesophageal reflux disease
2. Gastroesophageal reflux disease
3. The second canadian gastroesophageal reflux disease consensus: Moving forward to new concepts
4. Medical treatment of gastroesophageal reflux in the managed care environment
5. The economics of therapy of gastroesophageal reflux disease
6. Methodological aspects of evaluation of quality of life in upper gastrointestinal diseases
7. Incidence, epidemiology, and etiology of esophageal cancer
8. Socioeconomic status and risk of adenocarcinoma of the oesophagus and cancer of the gastric cardia in Scotland
9. Trends in incidence of adenocarcinoma of the oesophagus and gastric cardia in ten European countries
10. Symptomatic gastroesophageal reflux as a risk factor for esophageal adenocarcinoma
11. Omeprazole or ranitidine in the treatment of reflux esophagitis. Results of a double-blind, randomized, Scandinavian multicenter study
12. Omeprazole versus ranitidine or ranitidine/metoclopramide in poorly responsive symptomatic gastroesophageal reflux disease
13. Omeprazole or high-dose ranitidine in the treatment of patients with reflux oesophagitis not responding to 'standard doses' of H2-receptor antagonists
14. Comparison of lansoprazole and ranitidine in the treatment of erosive oesophagitis
15. Lansoprazole 30 mg daily versus ranitidine 150 mg bd in the treatment of acid-related dyspepsia in general practice
16. Lanosprazole versus ranitidine in the maintenance treatment of reflux oesophagitis
17. Large trial compares lansoprazole to omeprazole
18. Are there any differences in symptom relief and healing esophagitis between proton pump inhibitors: A meta-analysis of comparative trials
19. On the combination of independent two sample test of Wilcoxon
20. The quality of life following antireflux surgery
21. Quality of life in patients with upper gastrointestinal symptoms. An improved evaluation of treatment regimens?
22. Clinical effectiveness and quality of life with ranitidine vs placebo in gastroesophageal reflux disease patients: A clinical experience network (CEN) study